International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 721-725 doi: 10.5281/zenodo.16890391
Case Report
Sternal Mystery: Granulomatous Mass Post-BCG In An Infant – A Rare Surgical Encounter
 ,
 ,
 ,
 ,
 ,
Published
Aug. 17, 2025
Abstract

Background: The Bacillus Calmette-Guérin (BCG) is a vaccine which is widely administered in newborns to protect against tuberculosis. Although generally safe, BCG vaccination can occasionally lead to uncommon local or systemic complications, including granulomatous inflammation at sites distant from the inoculation site [1,2].

Case Presentation: A case report of a 7-month-old previously healthy male infant, presented with a firm, non-tender anterior sternal mass of three weeks’ duration. There were no systemic symptoms, No history of trauma, or no known infectious exposures. Imaging revealed a well-circumscribed soft tissue mass anterior to the sternum without underlying bony involvement. Histopathological examination following surgical excision demonstrated granulomatous inflammation, with no evidence of acid-fast bacilli or malignancy. Given the patient’s history of neonatal BCG vaccination and exclusion of alternative diagnoses, a diagnosis of BCG vaccine-associated granulomatous inflammation was made [3,4].

Management and Outcome: The patient underwent wide local excision of the mass and sent for histopathological evaluation. Postoperative recovery was uneventful. Wound was reviewed on post operative day 3 and 10. Follow up was done after 3 months.

Conclusion: This case highlights an unusual presentation of BCG vaccine-related granulomatous inflammation as an isolated sternal mass in infancy. Awareness of such rare post-vaccination complications is crucial for prompt diagnosis and appropriate surgical management to achieve complete resolution and avoid unnecessary delays in care [5].

 

 

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
821 Views
458 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved